166 related articles for article (PubMed ID: 15683364)
1. Distinct requirements for the Sprouty domain for functional activity of Spred proteins.
King JA; Straffon AF; D'Abaco GM; Poon CL; I ST; Smith CM; Buchert M; Corcoran NM; Hall NE; Callus BA; Sarcevic B; Martin D; Lock P; Hovens CM
Biochem J; 2005 Jun; 388(Pt 2):445-54. PubMed ID: 15683364
[TBL] [Abstract][Full Text] [Related]
2. The Sprouty-related protein, Spred, inhibits cell motility, metastasis, and Rho-mediated actin reorganization.
Miyoshi K; Wakioka T; Nishinakamura H; Kamio M; Yang L; Inoue M; Hasegawa M; Yonemitsu Y; Komiya S; Yoshimura A
Oncogene; 2004 Jul; 23(33):5567-76. PubMed ID: 15184877
[TBL] [Abstract][Full Text] [Related]
3. Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1.
Sasaki A; Taketomi T; Kato R; Saeki K; Nonami A; Sasaki M; Kuriyama M; Saito N; Shibuya M; Yoshimura A
Nat Cell Biol; 2003 May; 5(5):427-32. PubMed ID: 12717443
[TBL] [Abstract][Full Text] [Related]
4. Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors.
Yoshida T; Hisamoto T; Akiba J; Koga H; Nakamura K; Tokunaga Y; Hanada S; Kumemura H; Maeyama M; Harada M; Ogata H; Yano H; Kojiro M; Ueno T; Yoshimura A; Sata M
Oncogene; 2006 Oct; 25(45):6056-66. PubMed ID: 16652141
[TBL] [Abstract][Full Text] [Related]
5. Tissue-specific Spred-2 promoter activity characterized by a gene trap approach.
Bundschu K; Gattenlöhner S; Knobeloch KP; Walter U; Schuh K
Gene Expr Patterns; 2006 Mar; 6(3):247-55. PubMed ID: 16378760
[TBL] [Abstract][Full Text] [Related]
6. Getting a first clue about SPRED functions.
Bundschu K; Walter U; Schuh K
Bioessays; 2007 Sep; 29(9):897-907. PubMed ID: 17691106
[TBL] [Abstract][Full Text] [Related]
7. The Sprouty-related protein, Spred-1, localizes in a lipid raft/caveola and inhibits ERK activation in collaboration with caveolin-1.
Nonami A; Taketomi T; Kimura A; Saeki K; Takaki H; Sanada T; Taniguchi K; Harada M; Kato R; Yoshimura A
Genes Cells; 2005 Sep; 10(9):887-95. PubMed ID: 16115197
[TBL] [Abstract][Full Text] [Related]
8. Eve-3: a liver enriched suppressor of Ras/MAPK signaling.
King JA; Corcoran NM; D'Abaco GM; Straffon AF; Smith CT; Poon CL; Buchert M; I S; Hall NE; Lock P; Hovens CM
J Hepatol; 2006 Apr; 44(4):758-67. PubMed ID: 16478641
[TBL] [Abstract][Full Text] [Related]
9. The protein tyrosine phosphatase, Shp2, is required for the complete activation of the RAS/MAPK pathway by brain-derived neurotrophic factor.
Easton JB; Royer AR; Middlemas DS
J Neurochem; 2006 May; 97(3):834-45. PubMed ID: 16573649
[TBL] [Abstract][Full Text] [Related]
10. Spred is a Sprouty-related suppressor of Ras signalling.
Wakioka T; Sasaki A; Kato R; Shouda T; Matsumoto A; Miyoshi K; Tsuneoka M; Komiya S; Baron R; Yoshimura A
Nature; 2001 Aug; 412(6847):647-51. PubMed ID: 11493923
[TBL] [Abstract][Full Text] [Related]
11. Effects of silibinin on cell growth and invasive properties of a human hepatocellular carcinoma cell line, HepG-2, through inhibition of extracellular signal-regulated kinase 1/2 phosphorylation.
Momeny M; Khorramizadeh MR; Ghaffari SH; Yousefi M; Yekaninejad MS; Esmaeili R; Jahanshiri Z; Nooridaloii MR
Eur J Pharmacol; 2008 Sep; 591(1-3):13-20. PubMed ID: 18599034
[TBL] [Abstract][Full Text] [Related]
12. Spreds are essential for embryonic lymphangiogenesis by regulating vascular endothelial growth factor receptor 3 signaling.
Taniguchi K; Kohno R; Ayada T; Kato R; Ichiyama K; Morisada T; Oike Y; Yonemitsu Y; Maehara Y; Yoshimura A
Mol Cell Biol; 2007 Jun; 27(12):4541-50. PubMed ID: 17438136
[TBL] [Abstract][Full Text] [Related]
13. Flagellin and lipopolysaccharide stimulate the MEK-ERK signaling pathway in chicken heterophils through differential activation of the small GTPases, Ras and Rap1.
Kogut MH; Genovese KJ; He H
Mol Immunol; 2007 Mar; 44(7):1729-36. PubMed ID: 17045653
[TBL] [Abstract][Full Text] [Related]
14. IGF-I and vasoactive intestinal peptide (VIP) regulate cAMP-response element-binding protein (CREB)-dependent transcription via the mitogen-activated protein kinase (MAPK) pathway in pituitary cells: requirement of Rap1.
Fernández M; Sánchez-Franco F; Palacios N; Sánchez I; Cacicedo L
J Mol Endocrinol; 2005 Jun; 34(3):699-712. PubMed ID: 15956341
[TBL] [Abstract][Full Text] [Related]
15. Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.
Manuvakhova M; Thottassery JV; Hays S; Qu Z; Rentz SS; Westbrook L; Kern FG
Oncogene; 2006 Sep; 25(44):6003-14. PubMed ID: 16682955
[TBL] [Abstract][Full Text] [Related]
16. The VASP-Spred-Sprouty domain puzzle.
Bundschu K; Walter U; Schuh K
J Biol Chem; 2006 Dec; 281(48):36477-81. PubMed ID: 16987806
[TBL] [Abstract][Full Text] [Related]
17. FGF signal interpretation is directed by Sprouty and Spred proteins during mesoderm formation.
Sivak JM; Petersen LF; Amaya E
Dev Cell; 2005 May; 8(5):689-701. PubMed ID: 15866160
[TBL] [Abstract][Full Text] [Related]
18. Molecular cloning of mammalian Spred-3 which suppresses tyrosine kinase-mediated Erk activation.
Kato R; Nonami A; Taketomi T; Wakioka T; Kuroiwa A; Matsuda Y; Yoshimura A
Biochem Biophys Res Commun; 2003 Mar; 302(4):767-72. PubMed ID: 12646235
[TBL] [Abstract][Full Text] [Related]
19. Tyrosines 303/343/353 within the Sprouty-related domain of Spred2 are essential for its interaction with p85 and inhibitory effect on Ras/ERK activation.
Meng S; Zhang M; Pan W; Li Z; Anderson DH; Zhang S; Ge B; Wang C
Int J Biochem Cell Biol; 2012 May; 44(5):748-58. PubMed ID: 22305891
[TBL] [Abstract][Full Text] [Related]
20. The C-terminal domain of Mnk1a plays a dual role in tightly regulating its activity.
Goto S; Yao Z; Proud CG
Biochem J; 2009 Sep; 423(2):279-90. PubMed ID: 19650764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
